Skip to Content

Ecallantide

In the US, Ecallantide (ecallantide systemic) is a member of the drug class miscellaneous coagulation modifiers and is used to treat Hereditary Angioedema.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

B06AC03

CAS registry number (Chemical Abstracts Service)

0460738-38-9

Chemical Formula

C305-H442-N88-O91-S8

Molecular Weight

7053

Therapeutic Categories

Treatment of hereditary angioedema

Plasma kallicrein inhibitor

Reduction of blood loss during cardiothoracic surgery

Chemical Name

[Glu²⁰,Ala²¹,Arg³⁶,Ala³⁸,His³⁹,Pro⁴⁰,Trp⁴²]tissue factor pathway inhibitor (human)-(20-79)-peptide, modified on reactive bond region Kunitz inhibitor 1 domain containing fragment (WHO )

Foreign Names

  • Ecallantidum (Latin)
  • Ecallantid (German)
  • Écallantide (French)
  • Ecalantida (Spanish)

Generic Names

Brand Name

International Drug Name Search

Glossary

TermDefinition
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide